Finerenone's Effect on Retinal Health in Chronic Kidney Disease

This study aims to explore the effects of a medication called Finerenone on eye health, specifically in patients who have chronic kidney disease (CKD). People with CKD often experience thinning in parts of the eye, such as the retina and choroid. The research is important because it seeks to understand if Finerenone can help improve or protect these eye structures, potentially leading to better vision outcomes for CKD patients. Improving eye health in these patients could be significant because it addresses a common yet challenging aspect of CKD that affects quality of life. In the study, participants will be divided into two groups, one receiving the Finerenone treatment and the other not receiving any treatment. All participants will undergo eye examinations, which include checking their field of vision and using a technique called optical coherence tomography (OCT) to measure different parts of the eye. These tests are done at the start, and then again after 1, 3, and 6 months to see if there are any improvements. In addition to eye tests, blood and urine samples will be taken to monitor kidney function and other health indicators. The study will assess changes in eye measurements and health parameters over time, providing a comprehensive view of how Finerenone might benefit CKD patients.